The FDA recently issued warning letters to 15 companies for illegally selling products containing cannabidiol, or CBD, according to a press release.
The warning letters state that the companies use product webpages, online stores and social media to market CBD products in interstate commerce; market CBD products as dietary supplements; and/or add CBD to human and animal foods, according to the release.
The FDA has only approved one product containing CBD — Epidiolex (GW Research Ltd.) — for the treatment of seizures in patients aged 2 years and older with (Read more...)
Uncategorized